MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
-3.67%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$446M
AUM Growth
+$446M
(-6.4%)
Cap. Flow
-$2.56M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Celldex Therapeutics
CLDX
|
$2.56M |
Sector Composition
| 1 | Healthcare | 95.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Exelixis
EXEL
$10.1B
| $314M | 70.35% | 12,841,798 | – | – |
|
2
Esperion Therapeutics
ESPR
$448M
| $99.6M | 22.32% | 2,679,835 | – | – |
|
3
Alkermes
ALKS
$4.78B
| $12.4M | 2.78% | 750,000 | – | – |
|
4
iShares MSCI India ETF
INDA
$9.17B
| $10.8M | 2.43% | 320,000 | – | – |
|
5
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $9.44M | 2.12% | 400,000 | – | – |
|
|
6
Celldex Therapeutics
CLDX
$1.47B
| – | – | -196,846 | Closed | -$2.56M |
|